Optimal gross tumor volume definition in lung-sparing intensity modulated radiotherapy for pleural mesothelioma: an in silico study

References

• Baas P, Fennell D, Kerr KM, ESMO Guidelines Committee, et al. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015;26S5:v31–9.
   Google Scholar
• Van Meerbeeck JP, Gaafar R, Manegold C, et al. Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. J Clin Oncol 2005; 23:6881–9.
   PubMed Web of Science ®Google Scholar
• Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003; 21:2636–44.
   PubMed Web of Science ®Google Scholar
• Scherpereel A, Astoul P, Baas P, et al. European Respiratory Society/European Society of Thoracic Surgeons Task Force. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J 2010; 35:479–95.
   PubMed Web of Science ®Google Scholar
• Cao C, Tian D, Park J, et al. A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma. Lung Cancer 2014; 83:240–5.
   PubMed Web of Science ®Google Scholar
• Bovolato P, Casadio C, Billè A, et al. Does surgery improve survival of patients with malignant pleural mesothelioma? A multicenter retrospective analysis of 1365 consecutive patients. J Thorac Oncol 2014; 9:390–6.
   PubMed Web of Science ®Google Scholar
• Reynders K, Illidge T, Siva S, et al. The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant. Cancer Treat Rev 2015;41:503–10.
   PubMed Web of Science ®Google Scholar
• Marcq E, Pauwels P, van Meerbeeck JP, et al. Targeting immune checkpoints: new opportunity for mesothelioma treatment? Cancer Treat Rev 2015;41:914–24.
   PubMed Web of Science ®Google Scholar
• Haas AR, Sterman DH. Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies. Clin Chest Med 2013;34:99–111.
   PubMed Web of Science ®Google Scholar
• Minatel E, Trovo M, Polesel J, et al. Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung. J Thorac Oncol 2012; 7:1862–6.
   PubMed Web of Science ®Google Scholar
• Minatel E, Trovo M, Polesel J, et al. Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up. Lung Cancer 2014;83:78–82.
   PubMed Web of Science ®Google Scholar
• Rosenzweig KE, Zauderer MG, Laser B, et al. Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2012; 83:1278–83.
   PubMed Web of Science ®Google Scholar
• Fodor A, Fiorino C, Dell'oca I, et al. PET-guided dose escalation tomotherapy in malignant pleural mesothelioma. Strahlenther Onkol 2011; 187:736–43.
   PubMed Web of Science ®Google Scholar
• Feigen M, Lee ST, Lawford C, et al. Establishing locoregional control of malignant pleural mesothelioma using high-dose radiotherapy and (18) F-FDG PET/CT scan correlation. J Med Imaging Radiat Oncol 2011;55:320–32.
   PubMed Web of Science ®Google Scholar
• Rimner A, Spratt DE, Zauderer MG, et al. Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2014;90:394–401.
   PubMed Web of Science ®Google Scholar
• Chance WW, Rice DC, Allen PK, et al. Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis. Int J Radiat Oncol Biol Phys 2015;91:149–56.
   PubMed Web of Science ®Google Scholar
• Van Zandwijk N, Clarke N, Henderson D, et al. Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. J Thorac Dis 2013;5:E254–307.
   PubMed Web of Science ®Google Scholar
• Heelan RT, Rusch VW, Begg CB, et al. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. AJR Am J Roentgenol 1999; 172:1039–47.
   PubMed Web of Science ®Google Scholar
• Patz EF, Jr, Shaffer K, Piwnica-Worms DR, et al. Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. Am J Roentgenol 1992;159:961–6.
   PubMed Web of Science ®Google Scholar
• Rusch VW. A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. Chest 1995; 108:1122–8.
   PubMed Web of Science ®Google Scholar
• Nickell LT, Jr.,Lichtenberger JP, 3rd, Khorashadi L, et al. Multimodality imaging for characterization, classification, and staging of malignant pleural mesothelioma. Radiographics 2014;34:1692–706.
   PubMed Web of Science ®Google Scholar
• Hallifax RJ, Haris M, Corcoran JP, et al. Role of CT in assessing pleural malignancy prior to thoracoscopy. Thorax 2015;70:192–3.
   PubMed Web of Science ®Google Scholar
• Bénard F, Sterman D, Smith RJ, et al. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest 1998;114:713–22.
   PubMed Web of Science ®Google Scholar
• Klabatsa A, Chicklore S, Barrington SF, et al. The association of 18F-FDG PET/CT parameters with survival in malignant pleural mesothelioma. Eur J Nucl Med Mol Imaging 2014;41:276–82.
   PubMed Web of Science ®Google Scholar
• Fotina I, Lütgendorf-Caucig C, Stock M, et al. Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy. Strahlenther Onkol 2012;188:160–7.
   PubMed Web of Science ®Google Scholar
• Brock KK, Dawson LA. Point: principles of magnetic resonance imaging integration in a computed tomography-based radiotherapy workflow. Semin Radiat Oncol 2014;24:169–74.
   PubMed Web of Science ®Google Scholar
• Heinrich MP, Jenkinson M, Gleeson FV, et al. Deformable multimodal registration with gradient orientation based on structure tensors. Ann BMVA 2011;2:1–11.
   Google Scholar